The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Escalating every six weeks instead of four: what I observed over eight months

This is a generated summary. It shows the 5 most-liked posts from a topic of 32, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
NN
n.nybergTL23 Jan 2025#6

Adding the measurement that post #5 says would settle it.

Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.

Filing this under things that are true until someone shows me otherwise.

30 likes 19mo
ZO
z.okonkwoTL28 Jan 2025#11

I would put moderate confidence on the mainstream reading of escalating every six weeks instead and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.

32 likes 19mo
KO
k.otieno_statsTL3Statistician10 Jan 2025#14
dr_okonkwo, post #10: The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long half-life, four weeks approaches steady state and you can assess the dose fairly. That is an argument for not going faster. It is not an argument against going slower. Go to post

Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose. Escalating before steady state means escalating on incomplete information about the dose you are on.

Happy to be the one who is wrong here if it settles the question.

16 likes in reply to #10 19mo
SB
s.balogunTL211 Jan 2025 · edited#15
c.lundgren, post #3: The confident answers on escalating every six weeks instead and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category. Go to post

My experience of escalating every six weeks instead contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.

24 likes in reply to #3 19mo
AA
a.adebayoTL220 Jan 2025#28
j.fonseca, post #9: If you are stepping up mainly because the schedule says so rather than because the current dose has stopped doing what you wanted, that is worth noticing before rather than afterwards. Go to post

Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind most disappointment.

I have seen it go both ways, which is why I hedge.

32 likes in reply to #9 18mo

Read the full topic (32 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
About the Dosing & titration category
Schedules, escalation intervals, dose reductions, and the arithmetic that connects a vial to a syringe mark. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
JMKILDNAW 4 350 4mo
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version
Posting this under the heading it deserves: Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Everything below is what sits behind that. I have read the maintained page…
JSSSIBSBSO+138 148 1.8k 2y
Follow-up: Where the four-week escalation interval comes from, and what it is not
Where the four-week escalation interval comes from, and what it is not Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about four-week escalation…
TNOBJEPPMV+131 147 47k 18mo
Micro-titration: a disputed topic, argued properly — one year on
Posting this under the heading it deserves: Micro-titration: a disputed topic, argued properly — one year on Everything below is what sits behind that. Reading back through what has been written here about…
NSKRSICPAC+63 68 35k 1d
Reaching a dose and staying there for a year: a longitudinal note
Reaching a dose and staying there for a year: a longitudinal note Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I still have a…
RFNRHC 2 763 15mo

Related topics — sharing the tags titration, worked example, dose reduction

TopicParticipantsRepliesViewsActivity
What to include when your question involves a laboratory result — a second dataset
What to include when your question involves a laboratory result — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. Question in the title. Context…
CBHBC 2 7k 23d
[2026 update] Clearance pathways and what renal impairment changes
On the subject in the title: Clearance pathways and what renal impairment changes Working notes rather than a conclusion. What changes if the standard account of Clearance pathways is wrong? I ask because I…
CWFTADMHSA+63 69 50k 13mo
How much context is too much context in a first post?
How much context is too much context in a first post? I have a specific reason for asking rather than idle curiosity, and the context is below. Counting it rather than describing it, because the count is the…
LSHVPMKJD+69 74 935 18d
Feature request: should a dose-equivalence tool exist at all?
Feature request: should a dose-equivalence tool exist at all? — that is the question, and I have not found it answered plainly anywhere I have looked. Reading back through what has been written here about…
GPMGSTNHVS+21 25 4.8k 18mo
About the Dosing & titration category
Schedules, escalation intervals, dose reductions, and the arithmetic that connects a vial to a syringe mark. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
JMKILDNAW 4 350 4mo